MENU
+Compare
ABOS
Stock ticker: NASDAQ
AS OF
Sep 15 closing price
Price
$1.26
Change
-$0.06 (-4.55%)
Capitalization
76.32M

ABOS Acumen Pharmaceuticals Forecast, Technical & Fundamental Analysis

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABOS with price predictions
Sep 15, 2025

ABOS sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ABOS moved above the 200-day moving average on September 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABOS advanced for three days, in of 211 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ABOS as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ABOS turned negative on September 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

ABOS moved below its 50-day moving average on September 10, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ABOS crossed bearishly below the 50-day moving average on September 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ABOS entered a downward trend on August 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.683) is normal, around the industry mean (20.594). P/E Ratio (0.000) is within average values for comparable stocks, (53.282). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.156). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (342.112).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABOS is expected to report earnings to fall 19.88% to -54 cents per share on November 17

Acumen Pharmaceuticals ABOS Stock Earnings Reports
Q3'25
Est.
$-0.54
Q2'25
Missed
by $0.17
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.13
Q3'24
Missed
by $0.14
The last earnings report on August 12 showed earnings per share of -68 cents, missing the estimate of -50 cents. With 201.16K shares outstanding, the current market capitalization sits at 76.32M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
427 Park Street
Phone
+1 434 297-1000
Employees
52
Web
https://www.acumenpharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEGOF8.00N/A
N/A
Aegon Ltd.
HNLGY9.22N/A
N/A
Hang Lung Group Ltd.
TGMR0.06N/A
N/A
Troy Gold & Mineral Corp.
OFSTF0.50N/A
-0.23%
Carbon Streaming Corporation
AMXEF1.87-0.06
-3.11%
Amex Exploration Inc.

ABOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with KYTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-4.55%
KYTX - ABOS
46%
Loosely correlated
-0.26%
FHTX - ABOS
45%
Loosely correlated
-3.85%
BEAM - ABOS
45%
Loosely correlated
+3.30%
CRBU - ABOS
45%
Loosely correlated
+1.67%
CELC - ABOS
44%
Loosely correlated
+0.29%
More